In a study of two individuals with familial ALS using a single intrathecal infusion of AAV encoding a microRNA targeting SOD1, the authors showed that AAV-targeted gene suppression in ALS offers a way to provide a sustained effect using a single dose [54]. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.